Astragaloside IV ameliorates diabetic nephropathy in <i>db/db</i> mice by inhibiting NLRP3 inflammasome‑mediated inflammation.

Int J Mol Med · 2021 · PMC8262660 · PMID 34278447

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0872

boldest claim

The sentences

a decreasing trendP<0.05actually significant

In the 12th week, the AS-IV administration group exhibited a decreasing trend in FBG compared with the vehicle- and benazepril-treated groups ( Fig. 1B ; P<0.05).

also in 47,180 other papers

an increasing trendP=0.0872so close (0.05 < p ≤ 0.1)

However, the IL-1β level exhibited an increasing trend, with no significant difference ( Fig. 4C ; P=0.0872).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.